Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Revenue

Celldex Therapeutics had revenue of $730.00K in the quarter ending June 30, 2025, a decrease of -70.78%. This brings the company's revenue in the last twelve months to $5.79M, down -30.27% year-over-year. In the year 2024, Celldex Therapeutics had annual revenue of $7.02M with 1.99% growth.

• Revenue (ttm): $5.79M
• Revenue Growth: -30.27%
• P/S Ratio: 236.81
• Revenue / Employee: $31,129
• Employees: 186
• Market Cap: 1.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.02M	137.00K	1.99%
Dec 31, 2023	6.88M	4.53M	192.02%
Dec 31, 2022	2.36M	-2.29M	-49.32%
Dec 31, 2021	4.65M	-2.77M	-37.30%
Dec 31, 2020	7.42M	3.85M	107.61%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.